Skip to content

Application of enhanced recovery after surgery in perioperative period of metabolic surgery

Application of enhanced recovery after surgery in perioperative period of metabolic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019704
Enrollment
Unknown
Registered
2018-11-24
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Group 1:Gastric bypass ERAS treatments
Group 2:Sleeve gastrectomy
Group 3:Sleeve gastrectomy + jejunal exclusion surgery

Sponsors

Jinshazhou Hospital Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Informed contest; 2. Aged 16 to 65 (including 16, 65 years old); 3. Male waist =90 cm, female waist =85 cm (non- mandatory); 4. T2DM course = 15; 5. 1/2 of fasting serum C-peptide = normal limit; 6.Estimated feasibility of laparoscopic gastric bypass or sleeve gastrectomy or sleeve gastrectomy + jejunal exclusion Surgery; 7. Body mass index (BMI) ?27.5 [body mass index (BMI) = weight (kg) ÷ height ^2 (m)] (there is one item conforms to topic): (1) =32.5; (2) 27.5<32.5(Having T2DM, Uncontrol blood sugar after lifestyle changes and medication and meet at least 2 additional features of metabolic syndrome or have comorbidities). 8. None absolute contraindications for abdominal surgery: (1) None severe liver and kidney dysfunction; (2) Preoperative ECOG Physical State rating 0/1; (3) Preoperative ASA score I, II (See the CRF for the specific scoring table); Note: 1) Features of Metabolic syndrome (IDF definitions) include: High triglyceride (fasting TG=1.70 mmol/l), Low HDL cholesterol (male fasting HDL-ch<1.03 mmol/l, female fasting HDL-ch<1.29 mmol/l), hypertension ( Arterial systolic blood pressure =130 mmHg or arterial diastolic pressure =85 mmhg,1 mmhg=0.133 kPa); 2) complications include abnormal glucose metabolism and insulin resistance, obstructive sleep apnea (OSAS), nonalcoholic fatty Hepatitis (NASH), endocrine dysfunction, hyperuricemia, Male sexual dysfunction, polycystic ovarian syndrome, deformed arthritis, renal dysfunction, especially cardiovascular risk factors or T2DM chronic complications.

Exclusion criteria

Exclusion criteria: 1. Inability to provide informed consent; 2. Other weight loss surgery,expect for gastric bypass or sleeve gastrectomy or sleeve gastrectomy + jejunal exclusion Surgery; 3. Prior abdominal operation; 4. Need for concurrent surgical treatment of other diseases or emergency surgery; 5. Mental disorders, behavioral intolerance or abuse of drugs or alcohol addiction or suffering from un-controllable psychiatric disorders; 6. Diagnosis of type 1 diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Length of stay;Early postoperative complications;Adverse events;Readmission;Hospitalization expenses;

Countries

China

Contacts

Public ContactWu liangping

Jinshazhou Hospital Guangzhou University of Chinese Medicine

drwulp@163.com+86 13802779137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026